Professor, Psychiatry, University of Texas Southwestern Medical Center, Southwestern Medical School
Psychiatry
Dr. Madhukar H. Trivedi, MD
|
|
Give Review
Dr. Madhukar H. Trivedi practices Psychiatry. He went to medical school at Baroda Medical College. Madhukar Trivedi has written publications. He has 102 publications published with PubMed. The lastest publication is: 'Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.'
Publications
- A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.
- Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
- On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users.
- Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
- Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry.
- Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES).
- ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
- Dose-dependent changes in cognitive function with exercise augmentation for major depression: Results from the TREAD study.
- Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: A discrete survival and growth mixture model.
- Self-rated measure of pain frequency, intensity, and burden: Psychometric properties of a new instrument for the assessment of pain.
- Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain...
- A Health Education Intervention as the Control Condition in the CTN-0037 STRIDE multi-site exercise trial: Rationale and Description.
- Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram.
- Adherence to Antidepressant Combinations and Monotherapy for Major Depressive Disorder: A CO-MED Report of Measurement-Based Care.
- Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended re...
- Brief report: Depression and history of suicide attempts in adults with new-onset Type 2 Diabetes.
- Relationship Between Obesity and Depression: Characteristics and Treatment Outcomes With Antidepressant Medication.
- Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
- Cognitive dysfunction in unipolar depression: Implications for treatment.
- A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive di...
- Pattern recognition analysis of anterior cingulate cortex blood flow to classify depression polarity.
- Modeling predictors, moderators and mediators of treatment outcome and resistance in depression.
- Response to stanton, reaburn, and rosenbaum.
- Evaluating and monitoring treatment response in depression using measurement-based assessment and rating scales.
- Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
- Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of fou...
- Evidence-based recommendations for the prescription of exercise for major depressive disorder.
- Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
- Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients.
- Do Menopausal Status and Use of Hormone Therapy Affect Antidepressant Treatment Response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STA...
- The effect of sildenafil on quality of life.
- Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for...
- Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
- Decline in cardiorespiratory fitness and odds of incident depression.
- Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
- Feasible Evidence-Based Strategies to Manage Depression in Primary Care.
- Response to blier letter.
- Depression Treatment in Patients With General Medical Conditions: Results From the CO-MED Trial.
- What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?
- Using algorithms and computerized decision support systems to treat major depression.
- Assessing anxious features in depressed outpatients.
- Effects of heart disease on depression treatment: results from the COMED study.
- Neural Correlates of Successful Response Inhibition in Unmedicated Patients With Late-Life Depression.
- Moderators of antidepressant response in major depression.
- Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance ...
- Changes in Depressive Symptoms and Social Functioning in the Sequenced Treatment Alternatives to Relieve Depression Study.
- Measurement-Based Care for Unipolar Depression.
- Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.
- Performance improvement CME: algorithms and EMRs in depression.
- Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severity.
- Using moderator-based algorithms and electronic medical records to achieve optimal outcomes in depression.
- Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression.
- Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.
- Concise associated symptoms tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality.
- Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder...
- Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study.
- Prospective trial of equine-assisted activities in autism spectrum disorder.
- Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison.
- Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.
- Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.
- Challenges and algorithm-guided treatment in major depressive disorder.
- Children of Depressed Mothers 1 Year After Remission of Maternal Depression: Findings From the STAR*D-Child Study.
- Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major dep...
- Antenatal depression: a rationale for studying exercise.
- Crisis of confidence: antidepressant risk versus benefit.
- The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessmen...
- Measurement-based care in psychiatric practice: a policy framework for implementation.
- Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study.
- The current crisis of confidence in antidepressants.
- Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents.
- Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study.
- Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.
- Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
- The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women.
- A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample.
- Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.
- Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report.
- Insomnia in patients with depression: a STAR*D report.
- Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death.
- Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial.
- Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall ...
- Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
- Health-related quality of life in depression: a STAR*D report.
- The impact of diabetes on depression treatment outcomes.
- Exercise in the treatment of depression.
- DATE: Depressed adolescents treated with exercise: Study rationale and design for a pilot study.
- What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.
- Release bias in accessing medical records in clinical trials: a STAR*D report.
- Treating partial responders to antidepressant treatment.
- Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.
- A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder.
- Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
- Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
- Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
- An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
- Voice response system to measure healthcare costs: a STAR*D report.
- Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention.
- Family history of depression and therapeutic outcome: findings from STAR*D.
- Telephone-based assessments to minimize missing data in longitudinal depression trials: a project IMPACTS study report.
- Treating depression to full remission.
- Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.
Schools
Medical College Baroda
Ss Genl Hospital
Baroda Med College
Henry Ford Hospital
University Genl Hospital
University Tex Sw Med Center
Doctors Specialties
- Psychiatry
Accepted Insurances
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- MultiPlan PPO
- PHCS Network PPO
Education
-
Henry Ford Hospital - Wayne State University -
Baroda Medical College
Hospital
-
University of Texas Southwestern Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Steve A. Roche, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William L. Thornton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. Quinn III, MD |
|
Dr. Ayodele O. Ayoade, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Babette Farkas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald A. Melchiode, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth Ucheoma, MD |
|
|
Dr. Maria C. Lopez-Rosario, MD |
|
|
Dr. Warren H. Charleston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua Wang, MD |
|
|
Dr. Peter C. Holm, MD |
|
|
Dr. Rohini Ravindran, MD |